CRD-102 for Right Heart Failure in Patients With Left Ventricular Assist Devices
Status:
Completed
Trial end date:
2019-05-30
Target enrollment:
Participant gender:
Summary
This is a Phase 1b/IIa, single centre, non-randomised open-label uncontrolled study to assess
safety, effect and PK of oral CRD-102 in patients with RHF associated with the presence of an
LVAD.